Mednet Logo
HomePrimary Care
Primary Care

Primary Care

Physician perspectives on preventive care, chronic disease management, and evidence-based primary care practice.

Recent Discussions

How do you approach the use of bisphosphonates in reproductive-aged women?

1 Answers

Mednet Member
Mednet Member
Rheumatology · Mobile Medical Care Inc

This is an extremely difficult situation. I think it would be better to change this question to a discussion of a woman of childbearing potential since a woman of reproductive age with osteoporosis could have hormone failure and therefore is not of childbearing potential per se. A woman with celiac ...

What workup do you recommend for patients with low back pain and imaging concerning for spina bifida occulta?

1 Answers

Mednet Member
Mednet Member
Neurology · Hospital for Special Surgery

In cases of suspected spina bifida occulta, imaging of the entire spine and Neurosurgery referral are usually recommended. MRI is generally considered the imaging modality of choice, which can also detect other coexisting abnormalities such as tethered cord, while CT can be helpful in better imaging...

What is your approach to treating tophaceous gout in patients whose uric acid is below 5 prior to initiating uric acid lowering therapy?

1 Answers

Mednet Member
Mednet Member
Rheumatology · Texas Tech University Health Sciences Center

The finding of tophi is associated with elevated total body uric acid. If this is a true serum uric acid, it is conceivable the patient is a high urine excretor to explain the low serum uric acid. Checking uric acid excretion could elucidate this. Alternatively, low serum uric acid level could be a ...

How do you counsel patients on driving who have PNEA?

2
5 Answers

Mednet Member
Mednet Member
Neurology · USF Health

No law or rule here, so case by case and good old clinical judgment. Event severity, type, frequency, etc.A couple of references:Asadi-Pooya, et al., PMID 32913946Benbadis et al., PMID 10897163

With the increasing reports of correlation of frontal fibrosing alopecia and titanium dioxide sunscreens, do you advise patients against the use of micronized sunscreens on the face?

1 Answers

Mednet Member
Mednet Member
Dermatology · University of Miami Health

Yes, I believe titanium nanoparticles can be a trigger, and I advise avoiding this ingredient in sunscreens and foundations.

What is your experience with using extended release intra-articular steroid preparations, such as Zilretta in patients with osteoarthritis?

1
2 Answers

Mednet Member
Mednet Member
Rheumatology · Rush University Medical Center

Intra-articular glucocorticoids have been used for decades to treat painful knee osteoarthritis. In the past, steroid preparations of relatively insoluble crystals such as triamcinolone hexacetonide were used with the intention of prolonging the duration of intraarticular action. Although the retent...

Do you measure testosterone in men who will be receiving ADT?

3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Columbia University Medical Center

I do check before starting ADT. I make sure to check after ADT completion as well. A post-treatment low PSA level in the setting of a low testosterone has a different meaning than a low PSA in the setting of a recovered testosterone. It also gives you a potential explanation for a slight temporary P...

Would you avoid the entire class of bisphosphonates if a patient develops an allergic reaction, or would you consider the use of an alternative bisphosphonate?

4
2 Answers

Mednet Member
Mednet Member
Rheumatology · UC Davis

Interesting question and an important clinical issue. If the adverse event or side effect was not serious, I would try another bisphosphonate. If it occurred on alendronate, I would try a low dose or risedronate and monitor. If the side effect occurred from the IV infusion, I also would try a low do...

Does romosozumab need to be followed immediately by an anti-resorptive agent to preserve BMD gains, or could you consider a drug holiday?

3
1 Answers

Mednet Member
Mednet Member
General Internal Medicine · University of New Mexico Health Sciences Center

A drug holiday after romosozumab is not appropriate, since we know from the phase 2 studies that BMD rapidly declines if it is not followed by antiresorptive therapy. I suggest starting an antiresorptive agent 1 month after the last dose of romosozumab, or soon thereafter. Studies show that Dmab aft...

How do you approach treating necrobiosis lipoidica, especially cases that have ulcerated?

1 Answers

Mednet Member
Mednet Member
Dermatology · University of Oklahoma

ILK for early lesions, Pentoxyphylline helps with pain, optimize glycemic control, doxycycline, unna boot/wound care.